பிரிட்டிஷ் தீவுகள் லூபஸ் மதிப்பீடு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரிட்டிஷ் தீவுகள் லூபஸ் மதிப்பீடு குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரிட்டிஷ் தீவுகள் லூபஸ் மதிப்பீடு குழு Today - Breaking & Trending Today

Saphnelo Approved for Systemic Lupus Erythematosus


Saphnelo Approved for Systemic Lupus Erythematosus
Credit: AstraZeneca.
The approval was based on data from 3 clinical studies that evaluated the efficacy and safety of Saphnelo in adults with moderate to severe SLE who were receiving standard therapy.
The Food and Drug Administration (FDA) has approved Saphnelo (anifrolumab-fnia) for the treatment of adults with moderate to severe systemic lupus erythematosus who are receiving standard therapy.
Type I interferons (IFNs) play a role in the pathogenesis of systemic lupus erythematosus (SLE). Anifrolumab-fnia, a human immunoglobulin G1 kappa monoclonal antibody, binds to subunit 1 of the type I IFN receptor and blocks the biologic activity of type I IFNs. ....

British Isles Lupus Assessment Group , Drug Administration , Composite Lupus Assessment , பிரிட்டிஷ் தீவுகள் லூபஸ் மதிப்பீடு குழு , கலப்பு லூபஸ் மதிப்பீடு ,